Fennec Pharmaceuticals (NASDAQ:FENC) reported quarterly losses of $(0.31) per share. This is a 93.75 percent decrease over losses of $(0.16) per share from the same period last year.
FedEx To Exceed Expectations In Q2 Despite Transport Sector Headwinds, Analyst Predicts
Citi analyst Christian Wetherbee maintained FedEx Corp (NYSE: FDX) as a top pick.